MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/lbr.0000000000000110

Медицинская библиотека · Journal of bronchology & interventional pulmonology · 2014

The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema.

Wood Douglas E, Nader Daniel A, Springmeyer Steven C, Elstad Mark R, Coxson Harvey O, Chan Andrew, Rai Navdeep S, Mularski Richard A, Cooper Christopher B, Wise Robert A, Jones Paul W, Mehta Atul C, Gonzalez Xavier, Sterman Daniel H, IBV Valve Trial Research Team

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Lung volume reduction surgery improves quality of life, exercise capacity, and survival in selected patients but is accompanied by significant morbidity. Bronchoscopic approaches may provide similar benefits with less morbidity.

METHODS

In a randomized, sham procedure controlled, double-blind trial, 277 subjects were enrolled at 36 centers. Patients had emphysema, airflow obstruction, hyperinflation, and severe dyspnea. The primary effectiveness measure was a significant improvement in disease-related quality of life (St. George's Respiratory Questionnaire) and changes in lobar lung volumes. The primary safety measure was a comparison of serious adverse events.

RESULTS

There were 6/121 (5.0%) responders in the treatment group at 6 months, significantly >1/134 (0.7%) in the control group [Bayesian credible intervals (BCI), 0.05%, 9.21%]. Lobar volume changes were significantly different with an average decrease in the treated lobes of -224 mL compared with -17 mL for the control group (BCI, -272, -143). The proportion of responders in St. George's Respiratory Questionnaire was not greater in the treatment group. There were significantly more subjects with a serious adverse event in the treatment group (n=20 or 14.1%) compared with the control group (n=5 or 3.7%) (BCI, 4.0, 17.1), but most were neither procedure nor device related.

CONCLUSIONS

This trial had technical and statistical success but partial-bilateral endobronchial valve occlusion did not obtain clinically meaningful results. Safety results were acceptable and compare favorably to lung volume reduction surgery and other bronchial valve studies. Further studies need to focus on improved patient selection and a different treatment algorithm.

TRIAL REGISTRY: ClinicalTrials.gov NCT00475007.

Для цитирования: Wood Douglas E, Nader Daniel A, Springmeyer Steven C, Elstad Mark R, Coxson Harvey O, Chan Andrew, Rai Navdeep S, Mularski Richard A, Cooper Christopher B, Wise Robert A, Jones Paul W, Mehta Atul C, Gonzalez Xavier, Sterman Daniel H, IBV Valve Trial Research Team. The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema.. Journal of bronchology & interventional pulmonology. 2014. DOI: 10.1097/lbr.0000000000000110.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.